BioLife Solutions Announces Third Quarter 2018 Financial Results

T-cell graphic

Revenue increases 79% to a record $5.3 million; achieves net income of $1.2 million On November 8, 2018,  BioLife Solutions, Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary biopreservation media products for cell and gene therapies, reported financial results and operational highlights for the three and nine months ended September 30, 2018. Revenue […]

This website uses cookies to ensure you get the best experience on our website.